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Abstract
Background: Japan has one of the highest five-year relative survival rates for colorectal cancer in the world, with
its own traditions of perioperative care and a unique insurance system. The benefits of enhanced recovery after
surgery (ERAS) protocols in the Japanese population have yet to be clarified.
Methods: We evaluated 352 consecutive cases of colorectal cancer resection at Tokyo Metropolitan Bokutoh
Hospital between July 2009 and November 2012. Of these, 95 cases were performed according to traditional
protocols (traditional group), and 257 according to ERAS protocols (ERAS group), which were introduced to the
hospital in July 2010. Primary endpoints included length of postoperative hospital stay, postoperative short-term
morbidity, and rate of readmission within 30 days. Intensive pre-admission counselling, no pre- and postoperative
fasting (provision of oral nutrition), avoidance of sodium/fluid overload, intraoperative warm-air body heating,
enforced postoperative mobilization, and multimodal team care were among the main changes brought about by
the introduction of ERAS protocols.
Results: The median (interquartile range) length of postoperative hospital stay was 10 (10–12.75) days in the
traditional group and seven (6–8) days in the ERAS group, i.e., a three-day reduction (p < 0.05) in the ERAS group.
Moreover, the proportion of patients discharged within one week dramatically increased from 1 % to 77 % in the
ERAS group. The overall incidence of grade 2 and 3 postoperative complications according to the Clavien-Dindo
classification was 9.5 % in the traditional group and 9.3 % in the ERAS group, and 30-day readmission rates were
8.3 % and 6.6 % in the traditional and ERAS groups, respectively. There were no significant differences between the
two groups. Although operative time and blood loss did not differ significantly between the two groups, the
volume of intraoperative infusion was significantly decreased in the ERAS group (p < 0.05), possibly due to ERAS
recommendations to avoid dehydration (i.e., avoidance of sodium/fluid overload, no preoperative fasting).
Conclusion: ERAS protocols for colorectal surgery helped reduce the length of postoperative hospital stay without
adversely affecting morbidity, indicating that ERAS protocols are feasible and effective in Japanese settings as well.
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Background
Enhanced recovery after surgery (ERAS), first introduced
in 2005 [1], is a combination of various perioperative pa-
tient care methods based on a multimodal approach that
integrates evidence-based interventions to reduce surgical
stress, maintain postoperative physiological function, and
accelerate recovery in patients undergoing major surgery.
The fundamental components of ERAS include patient
education, no fasting, optimal fluid management,
decreased tube use, opioid-sparing analgesia, and early
mobilization [1]. ERAS Society recommendations
regarding perioperative care in colorectal surgery are
continuously updated as new information becomes
available [2–4].
ERAS protocols are aimed primarily at achieving
early recovery, which leads to a shorter hospital stay
without adversely affecting morbidity. Many studies
have evaluated ERAS with a particular focus on changes
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in the length of hospital stay (LOS). Several meta-
analyses of randomized trials in colorectal surgery
showed a decrease in LOS with ERAS, compared with
traditional care, without compromising patient safety
[5]. However, LOS as a surrogate measure of recovery
has some issues, as it is influenced by a number of non-
clinical factors that differ by country, including cultural
and traditional background and insurance status. It
should also be noted that previous reports on the out-
comes of ERAS have been largely limited to European
countries and the United States [6, 7], with few studies
conducted in Japan and other Asian countries [8]. In
fact, some elements of ERAS do not always fit well in
the Japanese setting [9].
Japan has one of the highest five-year relative survival
rates for colorectal cancer in the world [10], which reflects
high-quality perioperative care and surgical techniques. In
Japan, D3 lymph node dissection is performed as a stand-
ard procedure for advanced colorectal cancer [11]; this is
not the case in Western countries. For lower rectal cancer,
the standard treatment in Asia is surgery including lateral
lymph node dissection (LLND) [12], whereas preoperative
chemoradiotherapy followed by surgery without LLND is
the common approach in Western countries. Also, peri-
operative care differs between Japan and Western countries
[13] (differences also exist among European countries). For
example, traditional perioperative care in Japan includes
nil per os for several days.
Japan also has a unique public health insurance sys-
tem, i.e., universal health care. As this national health in-
surance system covers 70-90 % of all medical costs,
patients in Japan need not pay much for hospital admis-
sion. Consequently, early discharge is not a priority, and
some patients are reluctant to accept shorter hospital
stays. The median LOS after colorectal cancer surgery
was 10–19 days in 2007 and 2008 [14].
ERAS protocols were introduced to Japan at around
2010 and have since spread steadily to clinical institu-
tions across the country [9]. However, it remains unclear
whether ERAS leads to a shorter LOS with safety
equivalent to that of traditional care in Japanese general
hospitals, given the country’s traditions and unique
health insurance system.
Recently, the utility and feasibility of ERAS for gastric
surgery have been reported in Japan [15, 16]. However, to
the best of our knowledge, no English report on the use of
ERAS protocols for colorectal surgery in Japan exists.
Therefore, this study aimed to evaluate the efficiency and
safety of ERAS protocols for colorectal cancer in Japan.
Methods
Study population
A total of 352 consecutive patients undergoing resec-
tions for primary colorectal cancer between July 2009
and November 2012 at Tokyo Metropolitan Bokutoh
Hospital, a standard Japanese general hospital, were in-
cluded in this study. Exclusion criteria were emergency
operations due to bowel obstruction caused by colorec-
tal cancer (n = 38), bowel perforation with peritonitis
(n = 12), and conversion surgery after long preoperative
chemotherapy (n = 2). Patients who underwent stoma
construction (n = 31) were also excluded, because they
usually require more than two weeks before discharge
in order to acquire sufficient stoma care skills. During
the first year of the study, patients were treated accord-
ing to care routines considered traditional at that time
in Japan (traditional group, n = 95). Since specific ERAS
protocols were introduced in July 2010, consecutive pa-
tients treated after 2010 were classified as the ERAS
group (n = 257). Thereafter, ERAS protocols have been
adopted as standard protocols for all patients undergo-
ing colorectal resection at our institution. Throughout
the study period, the same colorectal staff surgeon pri-
marily cared for all patients, and the same team of sur-
geons performed all procedures. The technical aspects
of surgery, such as the choice of staplers and other in-
struments, as well as the antibiotics used, did not differ
during the study period. This study was approved by
the Institutional Review Board (IRB) of Tokyo Bokutoh
Metropolitan Hospital (IRB code: 25 –Heisei23).
Perioperative protocols
The main differences between ERAS protocols adopted
by Tokyo Metropolitan Bokutoh Hospital and traditional
care practices (Table 1) include intensive pre-admission
counseling (by both surgeons and anesthesiologists), no
pre- and postoperative fasting (provision of oral nutri-
tion), no nasogastric tube use after operation, avoidance
of sodium/fluid overload, short incisions, intraoperative
warm-air body heating, enforcement of postoperative
mobilization, stimulation of gut motility (use of oral
magnesium oxide), early urinary catheter removal, and
multimodal team care. Some elements of ERAS, such as
the use of thoracic epidural anesthesia/analgesia and
avoidance of pre-anesthetic medication, had already
been practiced routinely as part of traditional periopera-
tive care at the time the study was initiated. The same
discharge criteria (e.g., ability to tolerate solid food, ad-
equate pain control, independence in basic activities of
daily living, patient consent to discharge) were used
throughout the study period.
Data collection
Patient demographic and perioperative data, including
sex, age, body mass index, American Society of Anes-
thesiologists (ASA) performance status, tumor location,
surgical approach, colorectal cancer stage, operative
time, blood loss, volume of intraoperative infusion,
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postoperative LOS, and complications, were collected.
Complications occurring within 30 days postoperatively
were defined as grade 2 or higher according to the
Clavien-Dindo classification. The number of dissected
lymph nodes, as confirmed by pathologists, was also
measured as an indicator of the quality of cancer
surgery.
Statistical analysis
Demographic and perioperative data are presented as me-
dians (interquartile range [IQR]), box and whisker plots
(25th and 75th percentiles), means ± SD, or numbers (%),
as appropriate. Unless otherwise stated, comparisons were
performed between the traditional and ERAS groups. Stat-
istical evaluations were performed using two-way analysis
of variance, Wilcoxon’s signed-ranks test for continuous
outcomes, and Fisher’s exact test for binary outcomes. All
statistical analyses were performed using the JMP11
software program (SAS institute Japan LTD., Tokyo,
Japan). P < 0.05 was considered statistically significant.
Results
Of the 352 consecutive colorectal cancer resections per-
formed at Tokyo Metropolitan Bokutoh Hospital that
met the inclusion criteria, 95 were in the traditional
group and 257 were in the ERAS group. Patient charac-
teristics are shown in Table 2. The two groups were
similar in sex, age, body mass index, ASA performance
status, and tumor location (all P > 0.05). The surgical ap-
proach varied between the two groups, with all opera-
tions being open surgeries in the traditional group, and
one-fifth performed laparoscopically in the ERAS group
(P < 0.05). This was due to the adoption of laparoscopic
surgery for colorectal cancer during the study period,
starting in July 2011. There was no significant difference
in the distribution of colorectal cancer stages. The num-
ber of dissected lymph nodes was 32.9 ± 20.2 in the trad-
itional group and 33.6 ± 19.7 in the ERAS group, with
no significant difference. These results suggest that suffi-
cient lymph node dissection was performed in both
groups. Overall compliance with ERAS protocols was
good. With regard to postoperative feeding, none of the
patients in the traditional group ate rice at postoperative
day (POD) 3, whereas 68 % of patients in the ERAS
group ate rice at POD3.
Intraoperative outcomes are summarized in Table 3.
Operative time and blood loss did not significantly
differ between the two groups. The volume of intraop-
erative infusion was significantly lower in the ERAS
group (P < 0.05).
Outcomes regarding LOS are shown in Fig. 1. The me-
dian (IQR) postoperative LOS was 10 (10–12) days in
the traditional group and seven (6–7) days in the ERAS
group, showing a three-day reduction in the ERAS group
Table 1 Changes in perioperative care
Traditional care ERAS
Preoperative counseling only by surgeons intensive (by both surgeons and anesthesiologists)
Preoperative fasting (oral intake) no food on the previous day normal diet until the previous evening
no drink after the previous noon drink oral hydration solution (OS-1R) until 3 hours before surgery*
Preoperative bowel preparation usually sometimes for colon cancer, and always for rectal cancer
Perioperative fluid management
(avoidance of sodium/fluid overload)
no yes (goal-directed fluid therapy)
Short incisions/lapascopic surgery no always
Intraoperative warm-air body heating sometimes always
Nasogastric tube used (remove at POD1) not used
Postoperative fasting no oral intake for 3 days postoperatively initiate oral hydration (OS-1R) on the morning of POD1*
start eating soup at POD5 start eating rice at POD3
Routine postoperative mobilization care yes (walk by POD2) enforced (walk in the morning of POD1)
Non-opiate oral analgesics/NSAIDs no given routinely
Stimulation of gut motility no yes (use of oral magnesium oxide)
Early urinary catheter removal no yes
Multimodal approach few cases every case
Anesthesia and analgesics combination of epidural analgesia and general anesthesis (use of remifentanil)
Avoidance of pre-anesthetic medication
(no pre-medication)
Yes
Abstinence from smoking and drinking Yes
*Three 500-ml plastic bottles of oral rehydration solution [OS-1R; Otsuka Pharmaceutical, Tokushima, Japan]
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(P < 0.05). In histograms and box and whisker plots
(25th, 75th percentiles) (Fig. 1), horizontal bars corres-
pond to median LOS (10 in the traditional group and
seven in the ERAS group), and rhombuses correspond
to mean LOS (12.7 and 8.2, respectively). The first and
third quartiles (10 and 12, 6 and 7, respectively) are rep-
resented by horizontal boundaries of the boxes. There
was a dramatic increase in the proportion of patients
who were discharged within one week, from 1 % in the
traditional group to 77 % in the ERAS group.
Since laparoscopic surgery, which is generally consid-
ered less invasive, was performed only in the ERAS
group, we compared the LOS between patients who
had undergone laparoscopic surgery and those who had
undergone open surgery within the ERAS group, in
order to account for differences due solely to the type
of surgical approach. A significant difference was found
in the median LOS between laparoscopic surgery (six
days) and open surgery (seven days) (P < 0.05).
Postoperative outcomes are summarized in Table 4.
Overall, 9.5 % of patients in the traditional group and
9.3 % in the ERAS group had one or more postoperative
complications. Rates of anastomotic leakage, postoperative
ileus, pneumonia, cardiac disorders, and overall complica-
tions did not significantly differ between the two groups.
While there was no mortality in the traditional group, one
patient in the ERAS group died during the postoperative
course due to myocardial infarction. The rate of reopera-
tion within 30 days was 2.1 % in the traditional group and
1.6 % in the ERAS group, with no significant difference.
There was also no significant difference in 30-day re-
admission rates between traditional and ERAS groups
(8.3 % and 6.6 %, respectively).
Discussion
Japan has one of the best outcomes in the world for
colorectal cancer treatment, and has its own traditions
of perioperative care along with a unique insurance sys-
tem. Whether or not the introduction of ERAS protocols
benefits the Japanese population has been unclear. In
the present study, we demonstrated that ERAS protocols
for colorectal surgery can be applied and integrated ef-
fectively in a general hospital setting in Japan. In other
words, ERAS protocols can help achieve faster patient
recovery without increasing postoperative morbidity or
readmission rates in Japan.
Although operative time and blood loss did not differ
between the two groups, the volume of intraoperative
infusion was significantly lower in the ERAS group.
This might be explained by ERAS recommendations to
avoid dehydration, i.e., the avoidance of sodium/fluid
overload and no preoperative fasting. All intraoperative
infusions were exclusively performed by anesthesiolo-
gists, suggesting the importance of the multimodal ap-
proach of ERAS.
In Japan, traditional perioperative care for gastrointes-
tinal surgery includes “nil per os for several days.” ERAS
protocols were introduced in Japan around 2010, and
have since spread steadily to clinical institutions across
the country. In 2012, the Japanese Society of Anesthesi-
ologists established guidelines for preoperative fasting
and oral rehydration therapy. Today, many hospitals in
Japan perform preoperative oral rehydration therapy
prior to gastrointestinal surgery [9].
In our study, different surgical approaches were used
in the traditional and ERAS groups, with all operations
being open surgeries in the traditional group, and ap-
proximately one-fifth of operations performed laparo-
scopically in the ERAS group. Laparoscopic colorectal
resection has been shown to reduce postoperative pain,
is generally considered less invasive, and is expected to
result in a shorter LOS compared to open surgery. The
JCOG0404 study, a randomized controlled trial in
Japan, evaluated laparoscopic versus open colorectal
surgery with D3 dissection, and reported that the LOS
was 10 days following laparoscopic surgery, as opposed
to 11 following open surgery [17]. The COLOR II
study, a randomized phase III trial that compared lap-
aroscopic surgery and open surgery for rectal cancer in
eight European countries, had similar findings: postop-
erative LOS was eight days for laparoscopic surgery and
nine for open surgery [18]. In both studies, the differ-
ence in LOS between laparoscopic surgery and open






n = 95 n = 257
Sex (male/female) 65/30 165/92
Age (years) 69.1 ± 9.0 68.8 ± 11.5
Body mass index (kg/m2) 22.3 ± 3.1 22.0 ± 3.5
ASA (1/2/3) 3/78/14 3/211/43




Number of retrieved lymph nodes 32.9 ± 20.2 33.6 ± 19.7
Stage (0/I/II/III/IV) 1/7/27/39/21 6/37/90/85/39
*p < 0.05
Table 3 Intraoperative outcomes
Traditional ERAS
Operative time (min) 222.3 ± 106.2 205.6 ± 70.5
Blood loss (gram) 639.0 ± 744.8 516.6 ± 740.2
Volume of intraoperative
infusion (ml)
3218.2 ± 2100.3 2232.7 ± 1168.6*
*p < 0.05
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surgery was significant, albeit by only one day [17, 18].
Our results were consistent in that the median LOS
was six days in patients undergoing laparoscopic sur-
gery, as opposed to seven days in those undergoing
open surgery, in the ERAS group. These findings sug-
gest that the reduction in LOS by three days, as ob-
served in the ERAS group compared to the traditional
group, was not due solely to laparoscopic surgery.
Both ERAS protocols and laparoscopic surgery repre-
sent recent major changes in colorectal perioperative
care that have led to improved clinical outcomes follow-
ing colorectal cancer surgery. However, questions have
been raised recently regarding whether or not the bene-
fits of laparoscopy still exist when open surgery is
optimized due to ERAS. In the United Kingdom, a mul-
ticenter randomized controlled trial of conventional ver-
sus laparoscopic surgery for colorectal cancer with an
ERAS program showed that, while patients treated by
experienced surgeons according to ERAS had similar
physical fatigue and patient-reported outcomes in both
groups, laparoscopic surgery significantly reduced the
LOS (median: laparoscopy, five days vs. open, seven
days) [19]. These results support the observation that
ERAS benefits colorectal cancer patients regardless of
surgical approach.
The major limitation of this study is that it was a his-
torical control study. As mentioned above, due to Japan’s
unique governmental health insurance system, some pa-
tients may prefer to stay in the hospital longer. As such,
LOS may not necessarily reflect the patient’s medical
and physical status. However, in recent years, hospitals
have been under increasing pressure to reduce LOS, as
the government sees that this could contribute to a re-
duction in national medical costs. In this context, it is
clear that the main purpose of introducing ERAS proto-
cols is the reduction of postoperative LOS. The actual
LOS might have been influenced by patients being pres-
sured by surgeons or medical staff to hasten discharge.
Conclusions
In summary, although Japan follows distinct protocols
to treat colorectal cancer as compared with European
Fig. 1 Postoperative length of hospital stay (LOS) is shown as a histogram and box and whisker plots (25th, 75th percentiles) for both traditional
and ERAS groups. Median LOS is indicated by horizontal bars, and mean LOS by rhombuses. Horizontal boundaries of the boxes represent the
first and third quartiles. *P < 0.05
Table 4 Postoperative outcomes
Traditional ERAS
Postoperative complications 9 (9.5 %) 24 (9.3 %)
anastomotic leakage 2 (2.1 %) 5 (1.9 %)
ileus 3 (3.1 %) 9 (3.5 %)
pneumonia 1 (1.0 %) 4 (1.6 %)
cardiac disorder 1 (1.0 %) 1 (0.4 %)
other 2 (2.1 %) 5 (1.9 %)
Readmission within 30 days 8 (8.3 %) 17 (6.6 %)
Reoperation within 30 days 2 (2.1 %) 4 (1.6 %)
Mortality 0 (0 %) 1 (0.4 %)
Shida et al. BMC Surgery  (2015) 15:90 Page 5 of 6
countries and the United States, and has a unique
health insurance system that allows patients to delay
discharge after surgery, the present study demonstrated
the effectiveness of ERAS protocols to speed up patient
recovery in Japan, without increasing postoperative
morbidity or readmission rates. Thus, colorectal ERAS
protocols should be applied and integrated in general
hospital settings in Japan.
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